Tasigna Atherosclerosis Risks Concealed from Doctors, Patients in U.S.: Lawsuit
Plaintiff had to undergo four coronary artery bypass grafts due to Tasigna atherosclerosis risks, the lawsuit states.
Plaintiff had to undergo four coronary artery bypass grafts due to Tasigna atherosclerosis risks, the lawsuit states.
Lawsuit claims Novartis purposefully hid risks of narrowing and hardening arteries to increase profits.